Employing a lower BMI cut off for obesity at ≥29 as assumption of high waist circumference, there was a borderline association between MetS and KRAS mutation in non recto-sigmoid cancers (p = 0.05), whilst no significant association was identified employing cut off ≥30 as per IDF guidelines. The gene discussed is KRAS; the disease is metabolic syndrome.